首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

MDI 和 DPI 市場規模、佔有率和成長分析：按產品類型、適應症、藥物分類、分銷管道、最終用戶和地區分類—2026-2033 年行業預測

市場調查報告書

商品編碼

2102570

MDI 和 DPI 市場規模、佔有率和成長分析：按產品類型、適應症、藥物分類、分銷管道、最終用戶和地區分類—2026-2033 年行業預測

MDI and DPI Market Size, Share, and Growth Analysis, By Product Type, By Indication, By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年07月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球 MDI 和 DPI 市場價值為 428.7 億美元，預計到 2033 年將從 2025 年的 456.1 億美元成長至 749.3 億美元，在預測期（2026-2033 年）內複合年成長率為 6.4%。

全球定量吸入器 (MDI) 和乾粉吸入器 (DPI) 市場正經歷強勁成長，這主要得益於慢性呼吸系統疾病發病率的上升以及新興經濟體治療可及性的改善。隨著人口老化，對持續維持治療的需求日益成長，製藥公司正與醫療設備製造商合作，開發創新組合吸入器，以提高患者依從性並減少住院次數。這一趨勢正在提升保險報銷率，降低患者自付費用，並增加處方量。監管獎勵和永續性措施進一步推動了銷售，例如在不同市場推出新產品。此外，人工智慧 (AI) 和物聯網 (IoT) 的進步正在將吸入器轉變為連線健診設備，以實現即時監測和預防性治療。這些創新透過整合醫療保健生態系統和數據驅動的方法，提高了治療依從性並最佳化了患者療效。

全球定量吸入器 (MDI) 和乾粉吸入器 (DPI) 市場按產品類型、適應症、藥物分類、分銷管道、最終用戶和地區進行細分。依產品類型分類，可分為定量吸入器 (MDI)、乾粉吸入器 (DPI)、呼吸道吸入器和其他產品。依適應症分類，可分為氣喘、慢性阻塞性肺病 (COPD)、過敏性呼吸道疾病和其他疾病。依藥物分類，可分為支氣管擴張劑、皮質類固醇、組合藥物和其他藥物。按分銷管道分類，可分為醫院藥房、零售藥房、線上藥房和其他管道。按最終用戶分類，可分為醫院、呼吸診所、居家醫療和其他機構。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球 MDI 與 DPI 市場成長要素

由於患者和醫療專業人員對早期療育在慢性呼吸系統疾病管理中的關鍵作用認知不斷提高，全球定量吸入器 (MDI) 和乾粉吸入器 (DPI) 市場正經歷顯著成長。定量噴霧吸入器(MDI) 和乾粉吸入器 (DPI) 已被公認為重要的治療選擇。醫療機構正擴大將吸入療法納入各種醫療機構的治療指南，而製造商也在不斷擴展產品線，以滿足日益成長的、對方便用戶使用型給藥系統的需求，從而提高治療依從性和臨床療效。此外，公共衛生機構正在進行宣傳宣傳活動，推廣正確的吸入方法，從而增強患者的信心，並支持市場的長期永續性。

全球MDI和DPI市場的限制因素

全球定量吸入器 (MDI) 和乾粉吸入器 (DPI) 市場面臨許多阻礙，主要原因是吸入裝置的安全性和有效性測試受到嚴格的監管要求。雖然這些法規在保障消費者權益方面發揮著至關重要的作用，但也導致研發週期延長和合規成本增加。這種複雜的監管環境阻礙了中小企業進入市場，並最終抑制了整體市場擴張。製造商往往被迫投入大量時間和資源來滿足有關文件、臨床試驗和品管系統的嚴格標準。此外，由於需要獲得多個地區的批准，通常還涉及額外的測試和繁瑣的核准程序，因此這項挑戰更加嚴峻。

全球MDI和DPI市場趨勢

全球定量吸入器 (MDI) 和乾粉吸入器 (DPI) 市場正經歷一場變革，其驅動力是旨在改善患者吸入體驗的先進製劑技術創新。製造商日益專注於開發最佳化粒徑一致性和藥物穩定性的下一代產品，這主要是為了響應生物製藥和個人化醫療日益成長的需求。製藥公司與材料科學家之間的合作正在推動這一進展，促成了有望改善氣霧劑性能、減少給藥頻率並拓展治療應用的製劑的開發。這些進步有望顯著改變呼吸系統市場的競爭格局，推動創新公司佔據市場領先地位，並為未來的全球成長鋪路。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

GlaxoSmithKline plc
AstraZeneca plc
Boehringer Ingelheim International GmbH
Chiesi Farmaceutici SpA
Teva Pharmaceutical Industries Ltd.
Cipla Limited
Viatris Inc.
Novartis AG
Orion Corporation
Kindeva Drug Delivery LP
H&T Presspart Manufacturing Ltd.
Berry Global Group, Inc.
AptarGroup, Inc.
Bespak Europe Ltd.
Recipharm AB
Phillips-Medisize Corporation
Nemera Development SA
Gerresheimer AG
Catalent, Inc.
LTS Lohmann Therapie-Systeme AG

結論與建議

簡介目錄

Product Code: SQMIG35B2420

Global Mdi And Dpi Market size was valued at USD 42.87 Billion in 2024 and is poised to grow from USD 45.61 Billion in 2025 to USD 74.93 Billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The global MDI and DPI market is experiencing robust growth, propelled by the rising incidence of chronic respiratory diseases and improved treatment accessibility in emerging economies. The increasing aging population fuels demand for ongoing maintenance therapies, prompting pharmaceutical companies to partner with device manufacturers in creating innovative combination inhalers that enhance patient adherence and reduce hospitalization rates. This trend fosters insurance reimbursement, lowering out-of-pocket expenses and boosting prescription volumes. Regulatory incentives and sustainability initiatives further drive revenue, exemplified by new product launches in diverse markets. Additionally, advancements in artificial intelligence and the Internet of Things are transforming inhalers into connected health instruments, enabling real-time monitoring and proactive treatments. These innovations enhance compliance and optimize patient outcomes through integrated health ecosystems and data-driven approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mdi And Dpi market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mdi And Dpi Market Segments Analysis

The global MDI and DPI market is segmented by product type, indication, drug class, distribution channel, end user and region. Based on product type, the market is segmented into Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Breath-Actuated Inhalers and Others. Based on indication, the market is segmented into Asthma, COPD, Allergic Respiratory Disorders and Others. Based on drug class, the market is segmented into Bronchodilators, Corticosteroids, Combination Drugs and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on end user, the market is segmented into Hospitals, Respiratory Clinics, Homecare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mdi And Dpi Market

The Global MDI and DPI market is experiencing significant growth due to heightened awareness among patients and healthcare professionals regarding the critical role of early intervention in managing chronic respiratory conditions. Metered-dose inhalers and dry powder inhalers have gained recognition as vital therapeutic options. Healthcare providers are increasingly incorporating inhalation therapies into treatment guidelines across various healthcare settings, while manufacturers are expanding their product offerings to cater to the rising demand for user-friendly delivery systems that enhance treatment adherence and clinical efficacy. Additionally, public health organizations are conducting educational campaigns to promote proper inhaler techniques, boosting patient confidence and supporting the market's long-term sustainability.

Restraints in the Global Mdi And Dpi Market

The Global MDI and DPI market faces significant constraints due to stringent regulatory requirements for the safety and efficacy testing of inhalation devices. While these regulations play a crucial role in ensuring consumer protection, they lead to extended development timelines and increased compliance costs. This complex regulatory landscape can deter small businesses from entering the market, ultimately hindering overall market expansion. Manufacturers often find themselves allocating extensive time and resources to meet the demanding standards for documentation, clinical trials, and quality systems. The challenge is further exacerbated by the necessity for multiple regional clearances, which involve additional testing and bureaucratic processes.

Market Trends of the Global Mdi And Dpi Market

The global MDI and DPI market is experiencing a transformative trend driven by advanced formulation innovations aimed at enhancing the inhalation experience for patients. Manufacturers are increasingly focused on developing next-generation products that optimize particle size consistency and medication stability, largely in response to the growing demand for biologics and personalized therapies. Collaborations between pharmaceutical companies and material scientists are fueling this progress, leading to formulations that promise improved aerosol performance, decreased dose frequencies, and expanded therapeutic applications. Such advancements are poised to disrupt the competitive landscape in the respiratory market, positioning innovators as leaders and paving the way for future growth on a global scale.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global MDI and DPI Market Size by Product Type & CAGR (2026-2033)

Market Overview
Metered Dose Inhalers (MDI)
Dry Powder Inhalers (DPI)
Breath-Actuated Inhalers
Others

Global MDI and DPI Market Size by Indication & CAGR (2026-2033)

Market Overview
Asthma
COPD
Allergic Respiratory Disorders
Others

Global MDI and DPI Market Size by Drug Class & CAGR (2026-2033)

Market Overview
Bronchodilators
Corticosteroids
Combination Drugs
Others

Global MDI and DPI Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Global MDI and DPI Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Respiratory Clinics
Homecare
Others

Global MDI and DPI Market Size & CAGR (2026-2033)

North America (Product Type, Indication, Drug Class, Distribution Channel, End User)
- US
- Canada
Europe (Product Type, Indication, Drug Class, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Indication, Drug Class, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Indication, Drug Class, Distribution Channel, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Indication, Drug Class, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orion Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindeva Drug Delivery L.P.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H&T Presspart Manufacturing Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berry Global Group, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bespak Europe Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recipharm AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phillips-Medisize Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera Development S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LTS Lohmann Therapie-Systeme AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments